Lung
surfactant protein B (SP-B) is an essential protein found
in the surfactant fluid at the air–water interface of the lung.
Exposure to the air pollutant ozone could
potentially damage SP-B and lead to respiratory distress. We have
studied two peptides, one consisting of the N-terminus of SP-B [SP-B(1–25)] and the other a construct of the N- and C-termini
of SP-B
[SP-B(1–25,63–78)], called SMB. Exposure
to dilute levels of ozone (∼2
ppm) of monolayers of each peptide at the air–water interface
leads to a rapid reaction, which is evident from an increase
in the surface tension. Fluorescence experiments revealed that this
increase in surface tension is accompanied by a loss of fluorescence
from the tryptophan residue at the interface. Neutron and X-ray reflectivity
experiments show that, in contrast to suggestions in the literature,
the peptides are not solubilized upon oxidation but rather remain
at the interface with little change in their hydration. Analysis of
the product material reveals that no cleavage of the peptides occurs,
but a more hydrophobic product is slowly formed together with an increased
level of oligomerization. We attributed this to partial unfolding
of the peptides. Experiments conducted in the presence of phospholipids
reveal that the presence of the lipids does not prevent oxidation
of the peptides. Our results strongly suggest that exposure to low
levels of ozone gas will damage SP-B, leading to a change in its structure.
The implication is that the oxidized protein will be impaired in its
ability to interact at the air–water interface with negatively
charged phosphoglycerol lipids, thus compromising
what is thought to be its main biological function.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.